# voize

**Source:** https://geo.sig.ai/brands/voize  
**Vertical:** Healthcare  
**Subcategory:** General  
**Tier:** Emerging  
**Website:** voize.de  
**Last Updated:** 2026-04-14

## Summary

Berlin AI voice documentation for 600+ nursing care facilities saving 39 min/shift at Charité; YC W22 $9M HV Capital-backed competing with Nuance DAX for healthcare documentation automation at $9.4M revenue.

## Company Overview

voize is a Berlin-based healthtech company — backed by Y Combinator (W22) with $9 million raised in a seed round led by HV Capital with redalpine and HPI Ventures — providing AI-powered voice documentation software that enables nurses and healthcare workers to dictate patient reports, vital signs, and care notes directly into smartphones, replacing the manual keyboard data entry that currently consumes 20-40% of nursing shift time in care facilities. Founded in 2021, voize serves 600+ care facilities in Germany (including Charité University Hospital, which measured a 39-minute time savings per nurse per shift after deploying voize), generating $9.4 million in revenue in 2024 with a 35-person team by targeting the structural documentation burden that is driving nursing workforce burnout and contributing to staff shortages across European healthcare systems.

voize's speech-to-documentation technology is tuned specifically for healthcare German-language terminology (medical abbreviations, drug names, ICD-10 diagnostic codes, care outcome language) that general-purpose speech recognition (Siri, Alexa, Google Voice) misrecognizes at unacceptable rates in clinical settings. Nurses speak naturally while performing care tasks — checking vital signs, administering medication, completing wound care — and voize transcribes, structures, and populates the relevant fields in care documentation systems (nursing home software, hospital information systems) in real time without requiring separate documentation sessions at a computer. The structured data output (rather than transcription-only) means voize generates machine-readable care records rather than free-text notes, enabling downstream analytics and quality assurance workflows.

In 2025, voize competes in the healthcare AI documentation and clinical voice technology market with Nuance DAX (Microsoft, NASDAQ: MSFT, AI ambient clinical documentation for physicians), Suki AI (clinical AI voice assistant, $70M raised), and Abridge (clinical documentation AI, $150M raised) for healthcare documentation automation adoption. The nursing documentation market is distinct from the physician ambient documentation market — nurses have different workflows, different care settings (long-term care, home care, rehabilitation), and different documentation requirements than the outpatient physician visit use case that Nuance DAX and Suki target. Germany's €40+ billion nursing care sector (driven by an aging population with 4+ million requiring professional care) and EU-mandated digital health records (the Patientenakte/TI-Messenger connectivity requirements) create regulatory tailwinds for voice-based documentation adoption. The 2025 strategy focuses on growing German acute hospital adoption beyond long-term care, expanding to Austria and Switzerland (same language market, similar care software ecosystems), and building the care quality analytics layer from structured voize documentation data.

## Frequently Asked Questions

### What is voize?
voize is a Berlin-based healthcare tech company founded in 2021 that revolutionizes healthcare documentation through AI speech recognition. The platform allows healthcare workers to speak their documentation into smartphones, and AI automatically generates accurate entries for patient records, vital signs, and medication logs.

### What products and services does voize offer?
voize offers an AI-powered speech-to-documentation platform specifically designed for healthcare settings. The service uses domain-specific speech recognition to automatically convert spoken input into structured entries for patient reports, vital signs, and medication logs, available through a subscription-based model.

### Who are voize's target customers?
voize serves healthcare institutions including care facilities and hospitals. The platform is designed for healthcare workers, particularly nurses, who need to complete documentation tasks as part of their daily workflow.

### When was voize founded?
voize was founded in 2021 and participated in Y Combinator's W22 batch.

### Where is voize located?
voize is based in Berlin, Germany.

### How much funding has voize raised?
voize raised $9M in seed funding led by HV Capital, with participation from Y Combinator, redalpine, and HPI Ventures. The funding is supporting expansion into hospitals and development of AI for broader industrial applications.

### What are voize's key achievements and metrics?
voize generated $9.4M in revenue in 2024 and is currently adopted in over 600 care facilities. A study at Berlin's Charité University Hospital showed an average documentation time reduction of 39 minutes per shift for healthcare workers using the platform.

### How does voize's technology work?
voize uses domain-specific AI speech recognition technology that processes spoken input from healthcare workers via smartphones. The AI then structures the content and automatically generates accurate entries for various healthcare documentation needs including patient reports, vital signs, and medication logs.

### How can healthcare facilities start using voize?
Healthcare institutions can access voize's platform through a subscription-based model. Specific contact or onboarding details are not provided in the available information.

### What recent developments has voize announced?
In 2024, voize achieved $9.4M in revenue with a team of 35 employees and secured $9M in seed funding. The company is expanding into hospitals and developing AI for broader industrial applications beyond healthcare documentation.

## Tags

healthtech, b2b, b2c, saas, ai-powered, automation, mobile-first

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*